| 8431695 |
Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases |
Stephen O'Connor, Jacques Dumas, Wendy Lee, Julie A. Dixon, David Cantin +13 more |
2013-04-30 |
|
| 8163932 |
Substituted indolealkanoic acids |
Michael Lee Jones, John H. Jones, Michael Van Zandt |
2012-04-24 |
|
| 7928239 |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas |
Jacques Dumas, Bernd Riedl, Uday Khire, Jill Wood, Robert Sibley +5 more |
2011-04-19 |
|
| 7659269 |
Substituted indolealkanoic acids |
Michael Lee Jones, John H. Jones, Michael Van Zandt |
2010-02-09 |
|
| 7517880 |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
Scott C. Miller, Martin Osterhout, Jacques Dumas, Uday Khire, Timothy B. Lowinger +9 more |
2009-04-14 |
|
| 7371763 |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
Jacques Dumas, Bernd Riedl, Uday Khire, Robert Sibley, Holia Hatoum-Mokdad +5 more |
2008-05-13 |
|
| 7304079 |
Substituted indolealkanoic acids |
Michael Lee Jones, John H. Jones, Michael Van Zandt |
2007-12-04 |
|
| 7109196 |
1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders |
Yamin Wang, William Bullock, Qingjie Liu, Sidney Liang, Donglei Liu +5 more |
2006-09-19 |
$1,753,000 |
| 7105514 |
Substituted indolealkanoic acids |
Michael Lee Jones, John H. Jones, Michael Van Zandt |
2006-09-12 |
|
| 6900205 |
1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders |
Yamin Wang, William Bullock, Qingjie Liu, Sidney Liang, Donglei Liu +5 more |
2005-05-31 |
$539,000 |
| 6784167 |
17-beta-hydroxysteroid dehydrogenase-II inhibitors |
Jill Wood, Jeremy Lee Baryza, Catherine Brennan, Soongyu Choi, James H. Cook, II +8 more |
2004-08-31 |
$292,000 |
| 6730794 |
Substituted indolealkanoic acids |
Michael Lee Jones, John H. Jones, Michael Van Zandt |
2004-05-04 |
|
| 6426344 |
Aryl and heteroaryl substituted indolealkanoic acids |
Michael Lee Jones, John H. Jones, Michael Van Zandt |
2002-07-30 |
|
| 6344476 |
Inhibition of p38 kinase activity by aryl ureas |
Gerald Ranges, William Scott, Michael Bombara, Deborah Rauner, Aniko Redman +4 more |
2002-02-05 |
|
| 6214991 |
Substituted indolealkanoic acids |
Michael Lee Jones, John H. Jones, Michael Van Zandt |
2001-04-10 |
|
| 5948793 |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release |
Melwyn Abreo, Nan-Horng Lin, David S. Garvey, Mark W. Holladay, Keith B. Ryther |
1999-09-07 |
$106,432,000 |
| 5914328 |
Heterocyclic ether compounds useful in controlling neurotransmitter release |
Nan-Horng Lin, Mark W. Holladay, Melwyn Abreo, Suzanne A. Lebold, Richard L. Elliott +1 more |
1999-06-22 |
$105,108,000 |
| 5843968 |
Symmetrical bis-heteroarylmethoxy-phenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
Clint D. W. Brooks, Pramila Bhatia, Teodozyj Kolasa, Andrew O. Stewart, Richard A. Craig |
1998-12-01 |
$55,715,000 |
| 5795900 |
Symmetrical bis-heteroaryl-methoxy-phenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
Clint D. W. Brooks, Pramila Bhatia, Teodozyj Kolasa, Andrew O. Stewart, Richard A. Craig |
1998-08-18 |
$100,917,000 |
| 5783586 |
Heteroarylmethoxyphenylthioalkyl carboxylates as inhibitors of leukotriene biosynthesis |
Teodozyj Kolasa, Clint D. W. Brooks |
1998-07-21 |
$62,828,000 |
| 5756531 |
Iminoxy derivatives of indole and indene compounds as inhibitors of prostaglandin biosynthesis |
Clint D. W. Brooks, Richard A. Craig, Teodozyji Kolasa, Jimmie Moore, Andrew O. Stewart |
1998-05-26 |
$26,140,000 |
| 5691351 |
Bis-(Heteroarylmethoxyphenyl)cycloalkyl carboxylates as inhibitors of leukotriene biosynthesis |
Teodozyj Kolasa, Clint D. W. Brooks |
1997-11-25 |
$78,715,000 |
| 5668150 |
Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
Clint D. W. Brooks, Teodozyj Kolasa |
1997-09-16 |
$32,770,000 |
| 5472958 |
2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function |
Richard L. Elliott, Nan-Horng Lin, Hana Kopecka, Mark W. Holladay |
1995-12-05 |
$90,532,000 |
